Audio Podcast
Drug Trial Begins Targeting Mitochondrial Diseases
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:22:51
- Mais informações
Informações:
Sinopse
Exclusive Interview with Dr. Guy Miller, CEO of Edison Pharma. On July 15, 2008 Edison Pharma and partner Penwest Pharmaceuticals announced that A0001, an "improved" variant of Coenzyme Q10 (CoQ10), has entered Phase 1 clinical development with healthy volunteers. Edison predicts trials in patients with inherited mitochondrial disease will begin in 2009.
